These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8362750)

  • 1. Endothelial function in congestive heart failure.
    Drexler H; Hayoz D; Münzel T; Just H; Zelis R; Brunner HR
    Am Heart J; 1993 Sep; 126(3 Pt 2):761-4. PubMed ID: 8362750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial dysfunction in chronic heart failure. Experimental and clinical studies.
    Drexler H; Hayoz D; Münzel T; Just H; Zelis R; Brunner HR
    Arzneimittelforschung; 1994 Mar; 44(3A):455-8. PubMed ID: 8185723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial function in chronic congestive heart failure.
    Drexler H; Hayoz D; Münzel T; Hornig B; Just H; Brunner HR; Zelis R
    Am J Cardiol; 1992 Jun; 69(19):1596-601. PubMed ID: 1598876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of endothelial function in chronic heart failure.
    Drexler H; Hornig B
    J Cardiovasc Pharmacol; 1996; 27 Suppl 2():S9-12. PubMed ID: 8723393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of increased availability of endothelium-derived nitric oxide precursor on endothelium-dependent vascular relaxation in normal subjects and in patients with essential hypertension.
    Panza JA; Casino PR; Badar DM; Quyyumi AA
    Circulation; 1993 May; 87(5):1475-81. PubMed ID: 8491002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired acetylcholine-mediated vasodilation in patients with congestive heart failure. Role of endothelium-derived vasodilating and vasoconstricting factors.
    Katz SD; Schwarz M; Yuen J; LeJemtel TH
    Circulation; 1993 Jul; 88(1):55-61. PubMed ID: 8391403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of chronic angiotensin-converting enzyme inhibition on endothelial function in patients with chronic heart failure.
    Drexler H; Kurz S; Jeserich M; Münzel T; Hornig B
    Am J Cardiol; 1995 Nov; 76(15):13E-18E. PubMed ID: 7484881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of nitric oxide in endothelium-dependent vasodilation of hypercholesterolemic patients.
    Casino PR; Kilcoyne CM; Quyyumi AA; Hoeg JM; Panza JA
    Circulation; 1993 Dec; 88(6):2541-7. PubMed ID: 8252665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of aging and atherosclerosis on endothelial and vascular smooth muscle function in humans.
    Al-Shaer MH; Choueiri NE; Correia ML; Sinkey CA; Barenz TA; Haynes WG
    Int J Cardiol; 2006 May; 109(2):201-6. PubMed ID: 16054252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physical training improves endothelial function in patients with chronic heart failure.
    Hornig B; Maier V; Drexler H
    Circulation; 1996 Jan; 93(2):210-4. PubMed ID: 8548890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal vasodilatory effect of endothelial stimulation in patients with chronic congestive heart failure.
    Elkayam U; Cohen G; Gogia H; Mehra A; Johnson JV; Chandraratna PA
    J Am Coll Cardiol; 1996 Jul; 28(1):176-82. PubMed ID: 8752811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of endothelin-1 on endothelium-derived vascular responsiveness in man.
    Krum H; Cranswick N; Pellizzer AM
    Clin Sci (Lond); 1998 Aug; 95(2):151-6. PubMed ID: 9680496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired endothelium-mediated vasodilation in the peripheral vasculature of patients with congestive heart failure.
    Katz SD; Biasucci L; Sabba C; Strom JA; Jondeau G; Galvao M; Solomon S; Nikolic SD; Forman R; LeJemtel TH
    J Am Coll Cardiol; 1992 Apr; 19(5):918-25. PubMed ID: 1552112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased vascular responsiveness to norepinephrine in rats with heart failure is endothelium dependent. Dissociation of basal and stimulated nitric oxide release.
    Teerlink JR; Gray GA; Clozel M; Clozel JP
    Circulation; 1994 Jan; 89(1):393-401. PubMed ID: 8281675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of inhibition of nitric oxide formation on basal vasomotion and endothelium-dependent responses of the coronary arteries in awake dogs.
    Chu A; Chambers DE; Lin CC; Kuehl WD; Palmer RM; Moncada S; Cobb FR
    J Clin Invest; 1991 Jun; 87(6):1964-8. PubMed ID: 2040689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of nitric oxide to metabolic coronary vasodilation in the human heart.
    Quyyumi AA; Dakak N; Andrews NP; Gilligan DM; Panza JA; Cannon RO
    Circulation; 1995 Aug; 92(3):320-6. PubMed ID: 7634444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic vasoconstriction induced by inhibition of nitric oxide synthesis is attenuated in conscious dogs with heart failure.
    Elsner D; Müntze A; Kromer EP; Riegger GA
    Cardiovasc Res; 1991 May; 25(5):438-40. PubMed ID: 1855247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal vascular responses in human chronic cardiac failure are both endothelium dependent and endothelium independent.
    Maguire SM; Nugent AG; McGurk C; Johnston GD; Nicholls DP
    Heart; 1998 Aug; 80(2):141-5. PubMed ID: 9813559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary endothelial dysfunction: hypertension and heart failure.
    Boulanger CM
    J Mol Cell Cardiol; 1999 Jan; 31(1):39-49. PubMed ID: 10072714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous nitric oxide protects against platelet aggregation and cyclic flow variations in stenosed and endothelium-injured arteries.
    Yao SK; Ober JC; Krishnaswami A; Ferguson JJ; Anderson HV; Golino P; Buja LM; Willerson JT
    Circulation; 1992 Oct; 86(4):1302-9. PubMed ID: 1394936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.